Search - tctmd.com

Displaying 361 - 380 of 665

Sort: Relevancy | Date

Presentation TVT 2017

A Practical Clinical Algorithm for Correctly Diagnosing and Managing Patients With Low Flow Aortic Stenosis

Presenter: David J. Cohen, Jeffrey J. Popma, Howard C. Herrmann

June 16, 2017

Presentation TVT 2017

A Model of TAVR (vs SAVR) Case Selection, Based Solely on Clinical and Anatomic Factors

Presenter: David J. Cohen, Jeffrey J. Popma, Martin B. Leon

June 16, 2017

Presentation TVT 2017

After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients?

Presenter: David J. Cohen, Jeffrey J. Popma, Vinod H. Thourani

June 16, 2017

Presentation TVT 2017

SURTAVI Vignette III: Subset Analysis of Strokes

Presenter: David J. Cohen, Jeffrey J. Popma, A. Pieter Kappetein

June 16, 2017

Presentation TVT 2017

SURTAVI Vignette II: Subset Analysis of Patients With STS < 3% (Lower-Risk Patients)

Presenter: David J. Cohen, Jeffrey J. Popma

June 16, 2017

Presentation TVT 2017

SURTAVI Vignette I: Applying Bayesian Methodology to Interventional Clinical Trials

Presenter: David J. Cohen, Jeffrey J. Popma

June 16, 2017

Presentation TVT 2017

Spotlight Lecture: The SURTAVI LBCT: CoreValve vs Surgery in Intermediate-Risk Aortic Stenosis Patients

Presenter: David J. Cohen, Jeffrey J. Popma, Michael J. Reardon

June 16, 2017

Presentation TVT 2017

TAVR Bioskills & Imaging

Presenter: James M. McCabe

June 16, 2017

Presentation TVT 2017

Endogenous Tissue Restoration: Preclinical Investigation With Bioresorbable, Pulmonary, and Aortic Valves

Presenter: Patrick W. Serruys

June 16, 2017

Presentation TVT 2017

Aortic Root Pseudo-aneurysm Repair With Evolut-R CoreValve

Presenter: Shigeru Saito, Jonathon M. White, Brett Hiendlmayr, MD

June 16, 2017

Presentation TVT 2017

Prevalence of Amyloid in Patients Undergoing TAVR: Low-Flow Phenotype and Echocardiographic Predictors

Presenter: David J. Cohen, Mark J. Russo, Adam Castano

June 16, 2017

Presentation TVT 2017

Percutaneous Transcatheter Aortic Valve Closure to Treat Left Ventricular Assist Device-Associated Aortic Regurgitation

Presenter: Shigeru Saito, Jonathon M. White, Abdullah Alenezi, MD

June 16, 2017

Presentation TVT 2017

The Self-Expanding Single-Operator CENTERA TAVR System

Presenter: Didier Tchetche

June 16, 2017

Presentation TVT 2017

TAVR to Treat Aortic Regurgitation in LVAD Patients Rationale and Case Examples

Presenter: David J. Cohen, Mark J. Russo, Nir Uriel

June 16, 2017

Presentation TVT 2017

Potential Role of Outer Skirt of SAPIEN-3 Valve for Annular Rupture

Presenter: Shigeru Saito, Jonathon M. White, Mike Saji, MD

June 16, 2017

Presentation TVT 2017

The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR)

Presenter: A. Pieter Kappetein

June 16, 2017

Presentation TVT 2017

Lotus Aortic Valve Replacement in a Patient With Severe Aortic Valve Calcification: Making a Difference in TAVR

Presenter: Shigeru Saito, Jonathon M. White, Naseer Khan, MD

June 16, 2017

Presentation TVT 2017

Emergent TAVR for AS Patients With Intractable Heart Failure: Feasibility and Early Clinical Results

Presenter: David J. Cohen, Mark J. Russo, Ran Kornowski

June 16, 2017

Presentation TVT 2017

The Venus A-Valve and Venibri TAVR Systems Better for Bicuspids and Dry Leaflet Technology

Presenter: Horst Sievert

June 16, 2017

Presentation TVT 2017

Who Shouldnt Undergo TAVR? Can We Identify Non-responders?

Presenter: David J. Cohen, Mark J. Russo, Suzanne V. Arnold

June 16, 2017

Advertisement

A Practical Clinical Algorithm for Correctly Diagnosing and Managing Patients With Low Flow Aortic Stenosis

A Model of TAVR (vs SAVR) Case Selection, Based Solely on Clinical and Anatomic Factors

After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients?

SURTAVI Vignette III: Subset Analysis of Strokes

SURTAVI Vignette II: Subset Analysis of Patients With STS < 3% (Lower-Risk Patients)

SURTAVI Vignette I: Applying Bayesian Methodology to Interventional Clinical Trials

Spotlight Lecture: The SURTAVI LBCT: CoreValve vs Surgery in Intermediate-Risk Aortic Stenosis Patients

TAVR Bioskills & Imaging

Endogenous Tissue Restoration: Preclinical Investigation With Bioresorbable, Pulmonary, and Aortic Valves

Aortic Root Pseudo-aneurysm Repair With Evolut-R CoreValve

Prevalence of Amyloid in Patients Undergoing TAVR: Low-Flow Phenotype and Echocardiographic Predictors

Percutaneous Transcatheter Aortic Valve Closure to Treat Left Ventricular Assist Device-Associated Aortic Regurgitation

The Self-Expanding Single-Operator CENTERA TAVR System

TAVR to Treat Aortic Regurgitation in LVAD Patients Rationale and Case Examples

Potential Role of Outer Skirt of SAPIEN-3 Valve for Annular Rupture

The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR)

Lotus Aortic Valve Replacement in a Patient With Severe Aortic Valve Calcification: Making a Difference in TAVR

Emergent TAVR for AS Patients With Intractable Heart Failure: Feasibility and Early Clinical Results

The Venus A-Valve and Venibri TAVR Systems Better for Bicuspids and Dry Leaflet Technology

Who Shouldnt Undergo TAVR? Can We Identify Non-responders?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content